Increased expression of the Ras suppressor Rsu-1 enhances Erk-2 activation and inhibits Jun kinase activation

L Masuelli1, M L Cutler

  • 1Laboratory of Tumor Immunology and Biology, National Cancer Institute, Bethesda, Maryland 20892, USA.

Insights

The Ras suppressor Rsu-1 impacts Ras signaling by increasing SOS and GTP-bound Ras, while decreasing Ras GTPase-activating protein activity. This leads to enhanced Erk-2 activation and inhibited Jun kinase, ultimately suppressing Ras transformation.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Oncology

Background:

  • Ras signaling pathways are crucial in cell growth and differentiation.
  • Dysregulation of Ras signaling is implicated in various cancers.
  • Rsu-1 is a known Ras suppressor, but its precise role in Ras signal transduction remains unclear.

Purpose of the Study:

  • To investigate the effect of the Ras suppressor Rsu-1 on Ras signal transduction pathways.
  • To elucidate the molecular mechanisms by which Rsu-1 modulates Ras signaling components.
  • To determine the impact of Rsu-1 on downstream signaling kinases like Erk-2 and Jun kinase.

Main Methods:

  • Introduction of mouse rsu-1 cDNA into NIH 3T3 and PC12 cells.
  • Analysis of Ras pathway proteins, including SOS, GTP-bound Ras, and GTPase-activating protein (GAP).
  • Assays for Erk-2 and c-Jun amino-terminal kinase (Jun kinase) activity.
  • In vitro binding assays to detect Rsu-1 interaction with Raf-1.

Main Results:

  • Elevated p33rsu-1 expression increased SOS levels and GTP-bound Ras.
  • Rsu-1 expression decreased Ras GTPase-activating activity.
  • Erk-2 kinase activation was enhanced, while Jun kinase activation was inhibited by Rsu-1.
  • Rsu-1 directly binds to Raf-1, suggesting a role in pathway modulation.

Conclusions:

  • Rsu-1 modulates Ras signaling by altering the balance between Ras activation and inactivation.
  • Rsu-1 promotes Erk-2 activation while suppressing Jun kinase, indicating a switch in downstream signaling.
  • Inhibition of Jun kinase activation by Rsu-1 is sufficient to suppress Ras transformation, even with activated Erk-2.

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...